DNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access ...

Laigo Bio has completed the second close of its seed financing round at €5.5m, bringing the total raised to €17m ...

Ondine Biomedical has announced the North American phase 3 study has reached more than 93% enrolment, bringing the company ...

R1 Therapeutics has launched with an oversubscribed $77.5 million Series A financing and an exclusive global licence to ...

Axplora has announced plans to build a 4,500sqm R&D and laboratory hub at its Farmabios site in Gropello Cairoli in Italy ...

AlzeCure Pharma has released new preclinical findings for its lead Alzheimer’s drug candidate, NeuroRestore ACD856, following a presentation at the AD/PD 2026 international conference.

Compressed air is among the largest energy expenses in pharmaceutical manufacturing and must remain entirely ...

AEON Biopharma, a biopharmaceutical company, has appointed John Bencich as Chief Financial Officer (CFO) Bringing more than ...

Early trial shows more than 50% LRRK2 reduction and supports expansion into other neurodegenerative conditions ...

Samsung Bioepis has entered a new global agreement with Sandoz to develop and commercialise up to five next‑generation ...

Almirall has reported positive top-line results from its phase 3 ADorable-1 trial, which evaluated lebrikizumab in children ...

Helus Pharma, a clinical stage pharmaceutical company focused on developing novel serotonergic agonists (NSAs), has appointed ...